Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Mid-Cap · Nuveen / TIAA

Nuveen Small/Mid Cap Value Fund Class I (NSMRX)

Ticker NSMRX · Since 2006-12-15 · · Holdings as of Jun 30, 2026

Expense ratio
1.03%$103/yr per $10k
5-yr return
+14.3%annualized
1-yr return
+12.1%as of Dec 2025
Net assets
$132.4Mall share classes
Holdings
67

Bottom line

Is NSMRX a good fund? The bottom line

NSMRX is the Class I share class of Nuveen Small/Mid Cap Value Fund, an actively managed mid-cap mutual fund from Nuveen / TIAA.

Its expense ratio is 1.03% — about $103 a year on every $10,000 invested, more expensive than 64% of mid-cap funds we track.

It returned +12.1% over one year, +14.3% a year over five years, +10.8% a year over ten (as of Dec 31, 2025, per its prospectus).

With $132 million in net assets and 67 holdings, its largest position is State Street Bank And Trust Company (4.4%) and the top 10 make up 26.6% of the portfolio.

What stands out

  • 5-year return beat 99% of category peers
  • No front-end sales load

Updated Nov 19, 2026

What NSMRX invests in

The investment objective of the Fund is to provide investors with long-term capital appreciation.

Under normal circumstances, the Fund invests at least 80% of the sum of its net assets and the amount of any borrowings for investment purposes in equity securities of small-capitalization and mid-capitalization value companies. Small-capitalization and mid-capitalization companies are those that have market capitalizations within the market capitalization range of the companies in the Russell 2500 Index. The market capitalization range is determined based on the companies in the index as of the last business day of the month in which the index was most recently reconstituted and may be updated to reflect any changes to the index composition and the market capitalization of companies in the index. Value companies are those that are constituents of at least one of the following indexes on the last business day of the month in which its most recent reconstitution was completed (as…

From the fund's prospectus (filed Oct 28, 2026).

NSMRX performance

Average annual total returns
1 yr5 yr10 yr
NSMRX+12.1%+14.3%+10.8%
Mid-Cap median+7.9%+8.1%+9.9%

Source: Fund prospectus, as of Dec 31, 2025

Full NSMRX performance history →

What NSMRX costs

On a $10,000 investment, NSMRX's 1.03% expense ratio costs about $103 a year. The prospectus estimates $1,289 in total costs over 10 years (assuming 5% annual returns). The median mid-cap fund charges 0.88%.

See the full NSMRX fee table →

NSMRX top 10 holdings

#Holding% of fund
1State Street Bank And Trust Company4.36%
2MaxLinear Inc3.27%
3Viasat Inc2.78%
4Regal Rexnord Corp2.60%
5Pinnacle Financial Partners Inc2.47%
6BGC Group Inc2.40%
7Alkermes PLC2.21%
8Southstate Bank Corp2.18%
9Genworth Financial Inc2.17%
10Bio-Techne Corp2.15%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 26.6% of the fund. See all top 25 holdings and asset mix →

Alternatives to NSMRX

More funds like NSMRX →

NSMRX FAQ

What is the expense ratio of NSMRX?
NSMRX's expense ratio is 1.03%, which works out to about $103 a year for every $10,000 invested. The prospectus estimates total costs of $1,289 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is NSMRX a good investment?
It depends on your goals, but the data points to: 5-year return beat 99% of category peers; no front-end sales load. This is general information, not personalized advice.
What does NSMRX hold?
NSMRX's largest holdings are State Street Bank And Trust Company (4.4%), MaxLinear Inc (3.3%), Viasat Inc (2.8%), Regal Rexnord Corp (2.6%), Pinnacle Financial Partners Inc (2.5%). It holds 67 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is NSMRX's 5-year return?
NSMRX returned +14.3% a year over the five years ending Dec 31, 2025, and +10.8% a year over ten years. Past performance does not guarantee future results.
Does NSMRX have a sales load?
No. NSMRX has no front-end sales charge.
Who manages NSMRX?
NSMRX is offered by Nuveen / TIAA through Nuveen Investment Trust.